clinical trial · NCT03455725
CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial
Refractory AnginaChronic Myocardial IschemiaCardiAMP Cell Therapy SystemSham Treatment
brief summary
Prospective, multi-center, 2:1 randomized (Treatment : Sham Control), sham-controlled, double-blinded trial to compare treatment using the CardiAMP cell therapy system to sham treatment Treatment Group: Subjects treated with aBMC using the CardiAMP cell therapy system Sham Control Group: Subjects treated with a Sham Treatment (no introduction of the Helix transendocardial delivery catheter, no administration of aBMC)
started
Jun 30, 2021
primary completion
Feb 19, 2025
completion
Dec 1, 2027
last updated
Jan 6, 2026
official title
Randomized Controlled Pivotal Trial of Autologous Bone Marrow Cells Using the CardiAMP Cell Therapy System in Patients With Refractory Angina Pectoris and Chronic Myocardial Ischemia (CardiAMP CMI Trial)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol